Source: Mediators of inflammation. Unidade: FM
Subjects: ARTERIOSCLEROSE, HIPERCOLESTEROLEMIA, FATORES DE RISCO, ESTATINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JAMIALAHMADI, Tannaz et al. The effects of statin dose, lipophilicity, and combination of statins plus ezetimibe on circulating oxidized low-density lipoprotein levels: a systematic review and meta-analysis of randomized controlled trials. Mediators of inflammation, v. 2021, 2021Tradução . . Disponível em: https://doi.org/10.1155/2021/9661752. Acesso em: 12 out. 2024.APA
Jamialahmadi, T., Baratzadeh, F., Reiner, Z., Simental-mendia, L. E., Xu, S., Susekov, A. V., et al. (2021). The effects of statin dose, lipophilicity, and combination of statins plus ezetimibe on circulating oxidized low-density lipoprotein levels: a systematic review and meta-analysis of randomized controlled trials. Mediators of inflammation, 2021. doi:10.1155/2021/9661752NLM
Jamialahmadi T, Baratzadeh F, Reiner Z, Simental-mendia LE, Xu S, Susekov AV, Santos Filho RD dos, Sahebkar A. The effects of statin dose, lipophilicity, and combination of statins plus ezetimibe on circulating oxidized low-density lipoprotein levels: a systematic review and meta-analysis of randomized controlled trials [Internet]. Mediators of inflammation. 2021 ; 2021[citado 2024 out. 12 ] Available from: https://doi.org/10.1155/2021/9661752Vancouver
Jamialahmadi T, Baratzadeh F, Reiner Z, Simental-mendia LE, Xu S, Susekov AV, Santos Filho RD dos, Sahebkar A. The effects of statin dose, lipophilicity, and combination of statins plus ezetimibe on circulating oxidized low-density lipoprotein levels: a systematic review and meta-analysis of randomized controlled trials [Internet]. Mediators of inflammation. 2021 ; 2021[citado 2024 out. 12 ] Available from: https://doi.org/10.1155/2021/9661752